PILOT DEVELOPMENT OF NEW FORMS OF CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR KIDNEY CANCER.

$1,002,897FY2021Defense Health AgencyDOD

Yale Univ

Investigators

PILOT DEVELOPMENT OF NEW FORMS OF CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR KIDNEY CANCER. · GrantIndex